You have 9 free searches left this month | for more free features.

vascular endothelial growth factor (VEGF)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Iris Trial in Assiut (Immunohistochemistry analysis)

Not yet recruiting
  • Iris
  • Immunohistochemistry analysis
  • Assiut, Egypt
    Hassan Lotfy
Jul 29, 2022

Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

Recruiting
  • Retinal Vein Occlusion
  • Aflibercept Ophthalmic
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Jan 5, 2022

Ocular Adverse Events in Neovascular Age-related Macular

Completed
  • Age-related Macular Degeneration (AMD)
  • Aflibercept
  • +2 more
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)

Completed
  • Uveitis
  • Cystoid Macular Edema
  • Winston-Salem, North Carolina
    Wake Forest University Eye Center
Mar 7, 2022

Utilization of Cabozantinib in Adult Advanced or Metastatic

Withdrawn
  • Renal Cell Carcinoma
    • (no location specified)
    Dec 17, 2020

    Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

    Recruiting
    • Age Related Macular Degeneration
    • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
    • Xuzhou, Jiangsu, China
      XuZhou Central Hospital
    Feb 7, 2022

    Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

    Recruiting
    • Refractory Angina Pectoris
    • +2 more
    • Copenhagen, Denmark
    • +1 more
    Mar 3, 2021

    Maternal Serum Vascular Endothelial Growth Factor in Pregnant

    Recruiting
    • Foetal Growth Restriction
    • obstetric Ultrasound
    • serum Vascular Endothelial Growth Factor
    • Cairo, Egypt
      Nesreen Abdel Fattah Abdullah Shehata
    Jan 30, 2021

    Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

    Active, not recruiting
    • Diarrhea
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    Anti-VEGF in Real-world

    Recruiting
    • Neovascular Age-related Macular Edema
    • +5 more
    • Beijing, Beijing, China
      Wen-Bin Wei
    Feb 2, 2022

    Pre-eclampsia, Intra-uterine Growth Retardation Trial in Grenoble (blood sample and doppler Ultrasound of uterine arteries)

    Completed
    • Pre-eclampsia
    • Intra-uterine Growth Retardation
    • blood sample and doppler Ultrasound of uterine arteries
    • Grenoble, Isere, France
      Clinical investigation center of the Grenoble University Hospita
    Aug 27, 2021

    Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

    Completed
    • Neovascular Age-related Macular Degeneration
    • Wet Macular Degeneration
    • Palo Alto, California
    • +4 more
    Jun 5, 2020

    Acute Myeloid Leukemia, Adult Trial in Mexico city, Mexico City (Experimental group, Control group)

    Recruiting
    • Acute Myeloid Leukemia, Adult
    • Experimental group
    • Control group
    • Mexico city, Mexico
    • +1 more
    Sep 2, 2020

    Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

    Not yet recruiting
    • Exudative Age Related Macular Degeneration
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Aug 23, 2022

    Low Vision, Neovascular Age-related Macular Degeneration Trial in Baltimore (Vision rehabilitation)

    Completed
    • Low Vision
    • Neovascular Age-related Macular Degeneration
    • Vision rehabilitation
    • Baltimore, Maryland
      Wilmer Eye Institute
    Dec 13, 2019

    Metastatic Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v8, Stage IVA Colorectal Cancer AJCC v8 Trial in Columbus

    Recruiting
    • Metastatic Colorectal Carcinoma
    • +4 more
    • Bevacizumab
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Dec 14, 2021

    End Stage Renal Disease, Hemodialysis Vascular Access Failure Trial (1.25mg bevacizumab, 2.50mg bevacizumab)

    Withdrawn
    • End Stage Renal Disease
    • Hemodialysis Vascular Access Failure
    • 1.25mg bevacizumab
    • 2.50mg bevacizumab
    • (no location specified)
    Jul 6, 2020

    Retinal Pigment Epithelium Detachment in Neovascular Age-related

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • Anti-vascular endothelial growth factor therapy
    • Krasnodar, Russian Federation
      The S.N. Fyodorov Eye Microsurgery State Institution
    Jan 12, 2022

    Intermittent Claudication, Arteriosclerosis Trial in Birmingham, Bethesda, Madison (DNA Plasmid Vector, EW-A-401 DNA Plasmid

    Completed
    • Intermittent Claudication
    • Arteriosclerosis
    • DNA Plasmid Vector
    • EW-A-401 DNA Plasmid Vector
    • Birmingham, Alabama
    • +2 more
    Dec 11, 2019

    Neurofibromatosis Type 2, Progressive Vestibular Schwannomas Trial in United States (Bevacizumab)

    Completed
    • Neurofibromatosis Type 2
    • Progressive Vestibular Schwannomas
    • Los Angeles, California
    • +11 more
    Jan 26, 2021

    Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IIIC Lung Cancer AJCC v8 Trial in

    Recruiting
    • Metastatic Lung Non-Small Cell Carcinoma
    • +5 more
    • Bevacizumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 13, 2022

    Cardiac Complication, Vascular Diseases Trial in Paris (Cardiac complication induced by VEGF/VEGFR inhibitor)

    Completed
    • Cardiac Complication
    • Vascular Diseases
    • Cardiac complication induced by VEGF/VEGFR inhibitor
    • Paris, France
      AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
    Sep 24, 2019

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +8 more
    • Bevacizumab
    • Irinotecan Sucrosofate
    • Chicago, Illinois
      Northwestern University
    Mar 10, 2022

    Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma Trial in Houston (biological, drug, other)

    Active, not recruiting
    • Invasive Breast Carcinoma
    • Triple-Negative Breast Carcinoma
    • Bevacizumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 18, 2022

    Resectable Hepatocellular Carcinoma, Stage I Hepatocellular Carcinoma AJCC v8, Stage IA Hepatocellular Carcinoma AJCC v8 Trial

    Recruiting
    • Resectable Hepatocellular Carcinoma
    • +4 more
    • Atezolizumab
    • +2 more
    • Houston, Texas
    • +1 more
    Feb 4, 2022